866-997-4948(US-Canada Toll Free)

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Published By :

BCC Research

Published Date : May 2019

Category :

Biotechnology

No. of Pages : 232 Pages

"Summary

Population and human life expectancy are growing globally, spurring more chronic conditions and lifethreatening diseases. Obesity, a sedentary lifestyle and a lack of physical activity have further worsened the situation, leading to the increased importance of medical interventions and treatments. Despite incredible advancements in the field of medicine in the last few decades, an unmet need remains for the prevention, diagnosis and treatment of aggressive ailments such as cancer, cardiovascular diseases and central nervous system disorders.

Since the discovery of radioactivity, it has been recognized that radiation can play a role in the treatment of various diseases. Radiopharmaceuticals are a type of radioactive drug that is internally administered and intended for use in the diagnosis and treatment of diseases. Radiopharmaceuticals are now a crucial part of the healthcare industry, as they can identify various disease processes much earlier than other diagnostic tests. Applications of radiopharmaceuticals are growing significantly in the fields of cardiology, neurology, oncology and other medical specialties such as endocrinology, gastroenterology and nephrology, for both diagnostic and therapeutic purposes. Radiopharmaceuticals have also become an inevitable part of personalized medicine. Diagnostic applications account for morethan an REDACTED share of the global radiopharmaceutical market, and therapeutic applications constitutethe smaller part of the market. The market for therapeutic radiopharmaceuticals is expected to grow atsteep rate in the coming years, due to growing applications and increased demand.

Growing acceptance and utilization of nuclear medicine scans (i.e., SPECT and PET) and better availability of radiopharmaceuticals due to an increasing number of cyclotrons have significantly contributed to growth in the radiopharmaceutical industry. Innovative technological equipment leading to early and accurate diagnoses, increased awareness of radiopharmaceuticals among physicians and patients and new regulatory approvals of radiopharmaceuticals are other major driving forces for the global radiopharmaceutical market. Furthermore, increasing incidences of different types of cancers across the globe are considered a major driver behind the growth of radiopharmaceuticals and therapeutics. According to Our World in Data, approximately 19 million people had cancer in 1990; that has increased more than two-fold as of 2016, reaching 42 million worldwide. In addition, breast cancer
has been identified as the leading type of cancer, as eight million people had breast cancer in 2016. In the same year, 6.3 million, 5.7 million and 2.8 million people had colon and rectum cancer, prostate cancer and tracheal, bronchus and lung cancer, respectively. Hence, the increasing incidences of various cancers drives the need for radiopharmaceuticals and therapeutics, considering diagnostic and therapeutic areas.

The global radiopharmaceutical and therapeutics market is projected to rise at a CAGR of REDACTED during the forecast period of 2018 through 2023. In 2023, total revenues are expected to reach more than REDACTED, an increase of REDACTED from the REDACTED in revenue in 2017."

"Report Scope:

The scope of this report is broad and covers type, production method, technology and applications of radiopharmaceuticals and therapeutics. By type, the market has been segmented into radiotherapy and radiopharmaceuticals. Revenue forecasts from 2017 to 2023 are provided for each segment and regional market, with estimated values derived from manufacturers total revenues.

The report also includes a discussion of the major players in each region in the radiopharmaceutical and therapeutics market. Further, it explains the major drivers and regional dynamics of the global radiopharmaceutical and therapeutics market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and detailed profiles of the major vendors in this market.

Report Includes:

- 94 data tables and 83 additional tables
- An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
- Examination of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
- Detailed description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
- Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
- Coverage of new products launches and product enhancement in the industry
- Comprehensive company profiles of major players, including Accuray Inc., Bayer Pharma AG, C. R. Bard Inc., Eli Lilly and Company, Navidea Biopharmaceuticals Inc., Siemens Healthcare, and Triad Isotopes Inc."

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Executive Summary
Chapter 3 Market Overview
Introduction: Radiopharmaceuticals
Uses of Radiopharmaceuticals
Evolution and Transition: Radiopharmaceuticals
Introduction: Radiotherapy
Ionizing Radiation
Non-ionizing Radiation
Evolution and Transition: Radiation Therapy
The Discovery Period: 1890s
Kilovoltage Era: 1900 to 1940
Megavoltage Era: 1946 to 1996
Computer-Assisted Era: 1996 to the Present
Market Potential
Regulatory Outlook
United States
Canada
Australia
India
European Union
Investment Analysis
Market Share Analysis
Segmentation Overview
Segmentation by Type: Radiotherapy
Segmentation by Type: Radiopharmaceuticals
Segmentation by Production Method
Segmentation by Technology
Radiopharmaceutical and Therapeutics Market, by Application
Geographic Overview
North America
Europe
Asia-Pacific
RoW
Chapter 4 Market Dynamics
Trends
Respiratory Gating
Proton Therapy
Carbon Ions
Magnetic Resonance-Driven Linear Accelerator
Drivers
Increasing Aging Population
Increasing Incidence of Life-Threatening Diseases
Increasing Incidences of Cancer
High Incidence of Cancer in Aging Population
Growing Healthcare Spending in Emerging Regions
Advancements in Technology
Growing Focus on Early Diagnosis and Treatment
Launch of New Radiopharmaceuticals and Widening Applications
Increasing Number of Cyclotrons
Increasing Amount of Nuclear Imaging Equipment
High Efficiency of Radiotherapy
Palliative Radiation Therapy
Government Funding
Reimbursement Boosting Market Growth
Restraints and Challenges
Limited Global Supply of Medical Isotopes
Reimbursement Policies
Healthcare Reforms and Budgetary Constraints in Developed Countries
Regulatory Issues
Expensive Equipment
Lack of Trained Professionals
Limited Effectiveness against Metastatic Cancer
Side Effects of Radiation Therapy
Therapeutic Bottlenecks
Opportunities
Developing Countries
Personalized Treatment
Replacement of Old Equipment
Chapter 5 Global Radiopharmaceutical and Therapeutics Market by Type
Radiotherapy
External Beam Radiation Therapy
Internal Radiation Therapy
Systemic Radiotherapy
Radiopharmaceuticals
Diagnostics
Therapeutics
Chapter 6 Global Radiopharmaceutical and Therapeutics Market by Production Method
Particle Accelerators (Cyclotrons)
Working of Particle Accelerators
Nuclear Reactors
Radionuclide Generators
Production of Radioisotopes through Radionuclides
Chapter 7 Global Radiopharmaceutical and Therapeutics Market by Technology
External Radiotherapy Market by Technology
Particle Therapy/Proton Beam Therapy
Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiation Therapy
Image-Guided Radiation Therapy (IGRT)
Intensity-Modulated Radiation Therapy (IMRT)
Tomotherapy
Three-Dimensional Conformal Radiation Therapy (3D-CRT)
Volumetric Modulated Arc Therapy (VMAT)
Internal Radiotherapy by Technology
Pulsed-Dose-Rate (PDR) Brachytherapy
Low-Dose-Rate Brachytherapy
High-Dose-Rate (HDR) Brachytherapy
Systemic Radiotherapy by Technology
Comparison between Alpha and Beta Emitters
Chapter 8 Global Radiopharmaceutical and Therapeutics Market by Application
External Beam Radiation Therapy
Treatment Planning for External Beam Radiation
Dosing and Treatment with External Beam Radiation
Electron-Emitting High-Energy Linear Accelerators (LINACS)
Internal Radiation Therapy
Applications of Internal Beam Radiation Therapy
Systemic Radiation Therapy
Applications of Systemic Radiation Therapy
Chapter 9 Geographic Analysis
North America
United States
Canada
Europe
United Kingdom
France
Germany
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Rest of World (ROW)
Latin America
Middle East and Africa
Chapter 10 Industry Structure
Raw Material Procurement
Quality
Terms and Conditions
Cost-Effective Components
Manufacturing/Development Process
Distributors
End Users
Chapter 11 New Development and Current Situation
Pipeline Products
Current Market Scenario
Current Developments in Radiopharmaceuticals and Therapies
Chapter 12 Patent Analysis
U.S. Patent Analysis
European Patent Analysis
Japanese Patent Analysis
Chapter 13 Competitive Landscape
Product Launches
Collaborations, Agreements and Partnerships
Mergers and Acquisitions
Chapter 14 Company Profiles
ACCURAY INC.
ACTINIUM PHARMACEUTICALS INC.
ADVANCED ACCELERATOR APPLICATIONS SA (NOVARTIS CO.)
ADVANCED MEDICAL ISOTOPE CORP. (NOW VIVOS INC.)
ALLIANCE MEDICAL GROUP
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
AYTU BIOSCIENCE INC.
BAYER PHARMA AG
BLUE EARTH DIAGNOSTICS LTD.
BOARD OF RADIATION AND ISOTOPE TECHNOLOGY
BRACCO DIAGNOSTIC INC.
BTG INTERNATIONAL LTD.
C. R. BARD INC. (BECTON DICKINSON)
CARDINAL HEALTH INC.
CLARITY PHARMACEUTICALS
COQU RADIOPHARMACEUTICALS CORP.
ECKERT & ZIEGLER BEBIG
ELEKTA
ELI LILLY AND CO.
FUJIFILM RI PHARMA CO. LTD.
GE HEALTHCARE
IBA MOLECULAR (NOW CURIUM)
ISORAY MEDICAL INC.
ISO-TEX DIAGNOSTICS INC.
JUBILANT DRAXIMAGE INC.
LANTHEUS MEDICAL IMAGING INC.
NANOTHEA
NATIONAL CENTRE FOR NUCLEAR RESEARCH POLATOM
NATIONAL INSTITUTE FOR RADIOELEMENTS (IRE)
NAVIDEA BIOPHARMACEUTICALS INC.
NORDION INC.
NTP RADIOISOTOPES SOC LTD.
PHARMALUCENCE INC.
PMB ALCEN
SIEMENS HEALTHCARE GMBH (NOW SIEMENS HEALTHINEERS)
SPECTRUM PHARMACEUTICALS INC.
TRIAD ISOTOPES INC.
VARIAN MEDICAL SYSTEMS
ZEVACOR MOLECULAR

List of Table

List of Tables
Summary Table : Global Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
Table 1 : Milestones in the Discovery of Radioactivity and Nuclear Medicine
Table 2 : Prevalence of Different Cancers in Top Countries, 2016
Table 3 : Deaths from Cancers in Top Countries, by Cancer Type, 2016
Table 4 : Summary of Regulatory Affairs Across Countries
Table 5 : Investments in Radiopharmaceutical and Therapeutics Market
Table 6 : Global Radiopharmaceutical Market Share Analysis, by Company, 2017
Table 7 : Global Therapeutics Market Share Analysis, by Company, 2017
Table 8 : Global Geriatric Population (60 Years+), by Region, 2015, 2030 and 2050
Table 9 : Global Prevalence of Cancer, by Type, 2016
Table 10 : Major Types of Cancer Prevalence, by Region, 2015 and 2016
Table 11 : Need for Linear Accelerators and Radiotherapy Departments, 2015 and 2035
Table 12 : Global Radiotherapy Market, by Type, Through 2023
Table 13 : Global Cancer Prevalence and Cancer Mortality Rate, 2018 and 2030
Table 14 : Global Cancer Deaths, by Type, 2016
Table 15 : Global External Beam Radiotherapy Market, by Type, Through 2023
Table 16 : Global External Beam Radiotherapy Market, by Region, Through 2023
Table 17 : Global Electron-Emitting High-Energy Linear Accelerators Market, by Region, Through 2023
Table 18 : Global Compact Radiotherapy System Market, by Type, Through 2023
Table 19 : Global Compact Radiotherapy System Market, by Region, Through 2023
Table 20 : Global CyberKnife Market, by Region, Through 2023
Table 21 : Global Prevalence of Dementia, 2015, 2030 and 2050
Table 22 : Global Distribution of People Living with Dementia, by Region, 2015, 2030 and 2050
Table 23 : Global Gamma Knife Market, by Region, Through 2023
Table 24 : Global Tomotherapy Market, by Region, Through 2023
Table 25 : Global Proton Therapy System Market, by Type, Through 2023
Table 26 : Global Proton Therapy System Market, by Region, Through 2023
Table 27 : Global Cyclotron Market, by Region, Through 2023
Table 28 : Global Synchrotron Market, by Region, Through 2023
Table 29 : Global Internal Radiotherapy/Brachytherapy Market, by Type, Through 2023
Table 30 : Global Internal Radiotherapy/Brachytherapy Market, by Region, Through 2023
Table 31 : Global Brachytherapy Seed Market, by Region, Through 2023
Table 32 : Global Applicator and Afterloader Market, by Region, Through 2023
Table 33 : Global External Brachytherapy Market, by Region, Through 2023
Table 34 : Global Systemic Radiotherapy Market, by Region, Through 2023
Table 35 : Global Systemic Radiotherapy Market, by Type, Through 2023
Table 36 : Global Radiopharmaceutical Market, by Type, Through 2023
Table 37 : Global Deaths Caused by Chronic Diseases, by Type, 2015
Table 38 : Pharmaceutical Spending Share, by Country, 2016
Table 39 : Global Diagnostic Radiopharmaceutical Market, by Type, Through 2023
Table 40 : Global Diagnostic Radiopharmaceutical Market, by Region, Through 2023
Table 41 : Global PET Radiopharmaceutical Market, by Type of Radionuclide, Through 2023
Table 42 : Global SPECT Radiopharmaceutical Market, by Type of Radionuclide, Through 2023
Table 43 : Global Other Diagnostic Radiopharmaceuticals Market, by Type of Radionuclide, Through 2023
Table 44 : Global Therapeutic Radiopharmaceutical Market, by Type of Therapeutic, Through 2023
Table 45 : Global Therapeutic Radiopharmaceutical Market, by Region, Through 2023
Table 46 : Global Alpha Emitter Market, by Type of Radionuclide, Through 2023
Table 47 : Global Beta Emitters Market, by Type of Radionuclide, Through 2023
Table 48 : Global Brachytherapy Seeds Market, by Type of Radionuclide, Through 2023
Table 49 : Global Radiopharmaceuticals Market, by Production Method, Through 2023
Table 50 : Comparison of External Beam Radiation Therapy (EBRT) and Brachytherapy
Table 51 : Comparison of Technologies in Radiotherapy
Table 52 : Global External Radiotherapy Market, by Technology, Through 2023
Table 53 : Global Particle Therapy Market, by Region, Through 2023
Table 54 : Global Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy Market, by Region, Through 2023
Table 55 : Global Image-Guided Radiotherapy Market, by Region, Through 2023
Table 56 : Global Intensity-Modulated Radiotherapy Market, by Region, Through 2023
Table 57 : Comparison of Tomotherapy and Conventional Radiotherapy
Table 58 : Global Tomotherapy Market, by Region, Through 2023
Table 59 : Global Three-Dimensional Conformal Radiotherapy Market, by Region, Through 2023
Table 60 : Global Volumetric Modulated ARC Therapy Market, by Region, Through 2023
Table 61 : Advantages and Disadvantages of Brachytherapy
Table 62 : Various Types of Brachytherapy Implants
Table 63 : Brachytherapy Treatment Duration
Table 64 : Brachytherapy Treatment Dose Rate
Table 65 : Brachytherapy Treatment Source Loading
Table 66 : Comparison of Low-Dose and High-Dose Radiation Therapy
Table 67 : Benefits and Drawbacks of High-Dose-Rate (HDR) Brachytherapy
Table 68 : Comparison of Alpha and Beta Particles
Table 69 : Benefits and Drawbacks of Radiopharmaceuticals
Table 70 : Mechanisms of Radiopharmaceutical Localization
Table 71 : Global Radiotherapy Market, by Application, Through 2023
Table 72 : New Cancer Cases and Estimated Deaths, 2016
Table 73 : Global Number of Cancer Cases, 2012 and 2030
Table 74 : Estimates for Lung Cancer in the United States for 2018
Table 75 : Global External Beam Radiotherapy Market, by Application, Through 2023
Table 76 : Global Internal Beam Radiotherapy Market, by Application, Through 2023
Table 77 : Commonly Used Radionuclides (Radiation Sources) Half-Life for Brachytherapy
Table 78 : Global Systemic Radiotherapy Market, by Application, Through 2023
Table 79 : Global Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
Table 80 : North American Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
Table 81 : New Cancer Cases and Estimated Deaths, 2016
Table 82 : Aging U.S. Population, 2000-2050
Table 83 : North American Radiotherapy Market, by Type, Through 2023
Table 84 : New HIV Diagnoses in the United States, by Age Group, 2016
Table 85 : Healthcare Expenditures, by Source, Canada, 2015 and 2040
Table 86 : North American Radiopharmaceutical Market, by Type, Through 2023
Table 87 : Rising Aging Population (65 Years and Older) in Canada, 1996-2016
Table 88 : European Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
Table 89 : European Radiotherapy Market, by Type, Through 2023
Table 90 : Estimated Number of People Living with Cancer in U.K., by Country, 2015 and 2020
Table 91 : European Radiopharmaceutical Market, by Type, Through 2023
Table 92 : Health Spending and Financing, 2005-2015
Table 93 : Rising Geriatric Population in Germany, 2000-2030
Table 94 : Rising Number of Cancer Cases in Spain, 2012 and 2015
Table 95 : Estimate of Elderly People with Dementia (Aged 60+) in Denmark, 2017-2040
Table 96 : Asia-Pacific Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
Table 97 : Asia-Pacific Radiotherapy Market, by Type, Through 2023
Table 98 : Number of People with Cancer in China, 2010-2016
Table 99 : R&D Spending in India, by Top Pharmaceutical Companies
Table 100 : Japanese Pharmaceutical Industry, 2010-2015
Table 101 : Estimated Most Commonly Diagnosed Cancers, by Type, 2018
Table 102 : Commonly Diagnosed Cancer Cases in Australia, by Gender and Cancer Type, 2017
Table 103 : Asia-Pacific Radiopharmaceutical Market, by Type, Through 2023
Table 104 : Rest of World Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
Table 105 : Number of Cyclotrons Operating in Brazil, 2010-2015
Table 106 : Rest of World Radiotherapy Market, by Type, Through 2023
Table 107 : Share of Leading Causes of Deaths Related to Cancer in the UAE, by Cancer Type, 2015
Table 108 : Rest of World Radiopharmaceutical Market, by Type, Through 2023
Table 109 : Global Suppliers for the Radiopharmaceutical and Therapeutics Market
Table 110 : Selected Manufacturers of Instruments in Radiopharmaceutical and Therapeutics Market
Table 111 : Number of Cancer Deaths in Top Countries, by Type of Cancer, 2016
Table 112 : Radiopharmaceuticals in Clinical Trials, 2019
Table 113 : U.S. Patents on Radiopharmaceuticals and Therapeuticss, 2016-2018
Table 114 : European Patents on Radiopharmaceuticals and Therapeutics, 2016-2018
Table 115 : Japanese Patents and Patent Applications on Radiopharmaceuticals and Therapeutics, 2016-2018
Table 116 : Product Launches of Radiopharmaceuticals and Therapeutics
Table 117 : Collaborations, Agreements, and Partnerships in Radiopharmaceuticals and Therapeutics
Table 118 : Mergers and Acquisitions in Radiopharmaceuticals and Therapeutics
Table 119 : Accuray: Product Portfolio
Table 120 : Accuray: Recent Developments, 2016-2018
Table 121 : Actinium Pharmaceuticals Inc.: Product Portfolio
Table 122 : Actinium Pharmaceuticals Inc.: Recent Developments, 2016-2018
Table 123 : Advanced Accelerator Applications SA: Product Portfolio
Table 124 : Advanced Accelerator Applications SA: Recent Developments, 2016-2018
Table 125 : Advanced Medical Isotope Corp.: Product Portfolio
Table 126 : Advanced Medical Isotope Corp.: Recent Developments, 2016-2018
Table 127 : Alliance Medical Group: Product Portfolio
Table 128 : Alliance Medical Group: Recent Developments, 2016-2018
Table 129 : Australian Nuclear Science and Technology Organisation: Product Portfolio
Table 130 : Aytu BioScience Inc.: Product Portfolio
Table 131 : Bayer Pharma AG: Product Portfolio
Table 132 : Blue Earth Diagnostics Ltd.: Product Portfolio
Table 133 : Blue Earth Diagnostics Ltd.: Recent Development, 2016-2018
Table 134 : Board of Radiation and Isotope Technology: Product Portfolio
Table 135 : Bracco Diagnostics Inc.: Product Portfolio
Table 136 : Bracco Diagnostics Inc.: Recent Development, 2016-2018
Table 137 : BTG International Ltd.: Product Portfolio
Table 138 : BTG International Ltd.: Recent Developments, 2016-2018
Table 139 : C. R. Bard Inc.: Product Portfolio
Table 140 : C. R. Bard Inc.: Recent Developments, 2016-2018
Table 141 : Cardinal Health Inc.: Product Portfolio
Table 142 : Cardinal Health Inc.: Recent Developments, 2016-2018
Table 143 : Clarity Pharmaceuticals: Product Portfolio
Table 144 : Clarity Pharmaceuticals: Recent Developments, 2016-2018
Table 145 : Coqu RadioPharmaceuticals: Product Portfolio
Table 146 : Eckert & Ziegler BEBIG: Product Portfolio
Table 147 : Eckert & Ziegler BEBIG: Recent Developments, 2016-2018
Table 148 : Elekta: Product Portfolio
Table 149 : Elekta: Recent Developments, 2016-2018
Table 150 : Eli Lilly and Co.: Product Portfolio
Table 151 : Eli Lilly and Co.: Recent Developments, 2016-2018
Table 152 : Fujifilm RI Pharma Co. Ltd.: Product Portfolio
Table 153 : Fujifilm RI Pharma Co. Ltd.: Recent Developments, 2016-2018
Table 154 : GE Healthcare: Product Portfolio
Table 155 : GE Healthcare: Recent Developments, 2016-2018
Table 156 : IBA Molecular: Product Portfolio
Table 157 : IBA Molecular: Recent Developments, 2016-2018
Table 158 : IsoRay Medical Inc.: Product Portfolio
Table 159 : Iso-Tex Diagnostics Inc.: Product Portfolio
Table 160 : Jubilant DraxImage Inc.: Product Portfolio
Table 161 : Lantheus Medical Imaging Inc.: Product Portfolio
Table 162 : NanoThea: Product Portfolio
Table 163 : National Centre for Nuclear Research Radioisotope Centre POLATOM: Product Portfolio
Table 164 : National Institute for Radioelements: Product Portfolio
Table 165 : Navidea Biopharmaceuticals Inc.: Product Portfolio
Table 166 : Navidea Biopharmaceuticals Inc.: Recent Developments, 2016-2018
Table 167 : Nordion Inc.: Product Portfolio
Table 168 : NTP Radioisotopes SOC Ltd.: Product Portfolio
Table 169 : Pharmalucence Inc.: Product Portfolio
Table 170 : PMB ALCEN: Product Portfolio
Table 171 : Siemens Healthcare: Product Portfolio
Table 172 : Spectrum Pharmaceuticals Inc.: Product Portfolio
Table 173 : Triad Isotopes Inc.: Product Portfolio
Table 174 : Varian Medical Systems: Product Portfolio
Table 175 : Varian Medical Systems: Recent Developments, 2016-2018
Table 176 : Zevacor: Product Portfolio

List of Chart

List of Figures
Summary Figure : Global Radiopharmaceutical and Therapeutics Market, by Region, 2017-2023
Figure 1 : Types of Radiation
Figure 2 : Prevalence of Different Types of Cancers in Top Countries, 2016
Figure 3 : Deaths from Cancers in Top Countries, by Cancer Type, 2016
Figure 4 : Global Radiopharmaceutical Market Share Analysis, by Company, 2017
Figure 5 : Global Therapeutics Market Share Analysis, by Company, 2017
Figure 6 : Respiratory Gating Procedure
Figure 7 : Global Trends in Rising Aged Population, 2014-2022
Figure 8 : Heart Disease: Share of Mortalities in America, by Disease Type, 2017
Figure 9 : Prevalence of Cancer Across Global Regions, 2015 and 2016
Figure 10 : Global Aging Population, 1990-2050
Figure 11 : Factors Related to Aging and the Promotion of Cancer
Figure 12 : Global Prevalence of Cancer, by Type, 2016
Figure 13 : Rising Trends in Healthcare Spending, by Institution, 2015-2040
Figure 14 : Global Cancer Prevalence and Cancer Mortality Rate, 2018 and 2030
Figure 15 : Global Cancer Deaths, by Type, 2016
Figure 16 : Types of Beams Used in Radiation Therapy
Figure 17 : Common Types of Compact Advance Radiotherapy Systems
Figure 18 : Global Prevalence of Dementia, 2015, 2030 and 2050
Figure 19 : Global Distribution of People Living with Dementia, by Region, 2015, 2030 and 2050
Figure 20 : Global Deaths Caused by Chronic Diseases, by Type, 2015
Figure 21 : Pharmaceutical Spending Share, by Country, 2016
Figure 22 : Different Types of Diagnostic Radiopharmaceuticals
Figure 23 : Types of Therapeutic Radiopharmaceuticals
Figure 24 : Different Production Techniques of Radiopharmaceuticals
Figure 25 : Block Diagram of Particle Accelerators
Figure 26 : Block Diagram of External Radiotherapy Technologies
Figure 27 : Block Diagram of Particle Therapy/Proton Beam Therapy
Figure 28 : Block Diagram of Stereotactic Radiosurgery
Figure 29 : Procedure of Image-Guided Radiotherapy (IGRT)
Figure 30 : Block Diagram of Three-Dimensional Conformal Radiation Therapy (3D-CRT)
Figure 31 : Procedure of LDR Prostate Brachytherapy
Figure 32 : Types of External Radiation Therapy
Figure 33 : Global Number of Cancer Cases, 2012 and 2030
Figure 34 : Estimated New Cases of Leukemia, Lymphoma, and Myeloma, 2018
Figure 35 : New HIV Diagnoses in the United States, by Age Group, 2016
Figure 36 : Canadian Healthcare Expenditures, by Source, 2015 and 2040
Figure 37 : Rising Aging Population (65 Years and Older) in Canada, 1996-2016
Figure 38 : Health Spending and Financing, 2005-2015
Figure 39 : Rising Geriatric Population in Germany, 2000-2030
Figure 40 : Rising Number of Cancer Cases in Spain, 2012 and 2015
Figure 41 : Number of People with Cancer in China, 2010-2016
Figure 42 : R&D Spending in India, by Top Pharmaceutical Companies, 2017
Figure 43 : Japanese Pharmaceutical Industry, 2010-2015
Figure 44 : Estimated Most Commonly Diagnosed Cancers, by Type, 2018
Figure 45 : Industry Structure of Instruments and Medicines in the Radiopharmaceutical and Therapeutics Market

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *